Tobira Therapeutics, Inc. Common Stock
TBRA
TBRA was delisted on the 31st of October, 2016.
42 hedge funds and large institutions have $103M invested in Tobira Therapeutics, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 13 closing their positions.
1,668% more capital invested
Capital invested by funds: $5.8M → $103M (+$96.7M)
217% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 6
31% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 13
11% more funds holding
Funds holding: 38 → 42 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$39.4M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$14.1M |
| 3 |
CPV
Canaan Partners VII
Westport,
Connecticut
|
+$8.93M |
| 4 |
A
Abingworth
London,
United Kingdom
|
+$8.62M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$509K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$133K |
| 3 |
Bank of New York Mellon
New York
|
-$78K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$50.3K |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$43K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
SG Americas Securities
New York
| – | -$20K | -1,802 | Closed |
|
|
CC
52
Caxton Corporation
Princeton,
New Jersey
| – | -$14K | -1,259 | Closed |
|
|
TDC
53
Thompson Davis & Co
Richmond,
Virginia
| – | -$2K | -222 | Closed |
|
54
AllianceBernstein
Nashville,
Tennessee
| – | -$2K | -189 | Closed |
|
55
BNP Paribas Financial Markets
Paris,
France
| – | -$458 | -42 | Closed |
|
TBRA Hedge Fund Activity: Q2 2015 in Review
42 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Tobira Therapeutics, Inc. Common Stock (TBRA) for Q2 2015, worth a combined $103M — up 1,668% from $5.8M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new TBRA positions and 13 closed out — a net gain of 4 holders — while 19 added to existing stakes and 6 trimmed.
The largest buyer was Novo Holdings A/S, opening a new position worth an estimated $39.4M. The largest seller was Panagora Asset Management, exiting entirely with an estimated $509K sold.
- 42 institutional investors held Tobira Therapeutics, Inc. Common Stock (TBRA) as of Q2 2015, up from 38 in Q1 2015.
- Funds reported $103M of Tobira Therapeutics, Inc. Common Stock stock for Q2 2015, up 1,668% quarter-over-quarter.
- 17 funds opened new Tobira Therapeutics, Inc. Common Stock positions in Q2 2015 and 13 closed out, a net change of +4 holders.
- The largest Tobira Therapeutics, Inc. Common Stock buyer in Q2 2015 was Novo Holdings A/S, an estimated $39.4M added.
- The largest Tobira Therapeutics, Inc. Common Stock seller in Q2 2015 was Panagora Asset Management, an estimated $509K sold.
Based on aggregated 13F filings for Q2 2015.